Cystic Fibrosis

Overview

Journal BMJ

Specialty General Medicine

Date 2007 Dec 15

PMID 18079549

Citations 112

Authors

Jane C Davies

Eric W F W Alton

Andrew Bush

Affiliations

Soon will be listed here.

Citing Articles

Optogenetics with Atomic Precision─A Comprehensive Review of Optical Control of Protein Function through Genetic Code Expansion.

Charette M, Rosenblum C, Shade O, Deiters A Chem Rev. 2025; 125(4):1663-1717.

PMID: 39928721 PMC: 11869211. DOI: 10.1021/acs.chemrev.4c00224.

Polymicrobial interactions influence co-existence and biofilm forming capabilities.

Nandanwar N, Gu G, Gibson J, Neely M Front Microbiol. 2024; 15:1484510.

PMID: 39654682 PMC: 11627178. DOI: 10.3389/fmicb.2024.1484510.

Effect of Elexacaftor/Tezacaftor/Ivacaftor on Acquisition and Chronic Infection at a Single Pediatric Cystic Fibrosis Care Center.

Duehlmeyer S, Elson E, Oermann C J Pediatr Pharmacol Ther. 2024; 29(2):135-139.

PMID: 38596420 PMC: 11001205. DOI: 10.5863/1551-6776-29.2.135.

Combinatorial prediction of therapeutic perturbations using causally-inspired neural networks.

Gonzalez G, Lin X, Herath I, Veselkov K, Bronstein M, Zitnik M bioRxiv. 2024; .

PMID: 38260532 PMC: 10802439. DOI: 10.1101/2024.01.03.573985.

interactions with other microbes in biofilms during co-infection.

Oliveira M, Cunha E, Tavares L, Serrano I AIMS Microbiol. 2024; 9(4):612-646.

PMID: 38173971 PMC: 10758579. DOI: 10.3934/microbiol.2023032.

References

Orens J, Estenne M, Arcasoy S, Conte J, Corris P, Egan J . International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006; 25(7):745-55. DOI: 10.1016/j.healun.2006.03.011. View

Davies J, Alton E . Airway gene therapy. Adv Genet. 2005; 54:291-314. DOI: 10.1016/S0065-2660(05)54012-4. View

Rosenstein B, Cutting G . The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr. 1998; 132(4):589-95. DOI: 10.1016/s0022-3476(98)70344-0. View

Middleton P, Geddes D, Alton E . Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J. 1994; 7(11):2050-6. View

Southern K, Barker P, Solis A . Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2004; (2):CD002203. DOI: 10.1002/14651858.CD002203.pub2. View

Onady G, Stolfi A . Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database Syst Rev. 2005; (3):CD004730. DOI: 10.1002/14651858.CD004730.pub2. View

Colombo C, Russo M, Zazzeron L, Romano G . Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2006; 43 Suppl 1:S49-55. DOI: 10.1097/01.mpg.0000226390.02355.52. View

Davis P . Cystic fibrosis since 1938. Am J Respir Crit Care Med. 2005; 173(5):475-82. DOI: 10.1164/rccm.200505-840OE. View

Dodge J, Lewis P, Stanton M, Wilsher J . Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J. 2006; 29(3):522-6. DOI: 10.1183/09031936.00099506. View

10.

Deterding R, Retsch-Bogart G, Milgram L, Gibson R, Daines C, Zeitlin P . Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis. Pediatr Pulmonol. 2005; 39(4):339-48. DOI: 10.1002/ppul.20192. View

11.

Riordan J, Rommens J, Kerem B, Alon N, Rozmahel R, Grzelczak Z . Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245(4922):1066-73. DOI: 10.1126/science.2475911. View

12.

Wicks E . Cystic fibrosis. BMJ. 2007; 334(7606):1270-1. PMC: 1892499. DOI: 10.1136/bmj.39188.741944.47. View

13.

Jones A, Wallis C . Recombinant human deoxyribonuclease for cystic fibrosis. Cochrane Database Syst Rev. 2003; (3):CD001127. DOI: 10.1002/14651858.CD001127. View

14.

Smyth A, Walters S . Prophylactic anti-staphylococcal antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2012; 12:CD001912. DOI: 10.1002/14651858.CD001912.pub2. View

15.

Dezateux C, Crighton A . Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. Cochrane Database Syst Rev. 2000; (2):CD001505. DOI: 10.1002/14651858.CD001505. View

16.

Glasscoe C, Quittner A . Psychological interventions for cystic fibrosis. Cochrane Database Syst Rev. 2003; (3):CD003148. DOI: 10.1002/14651858.CD003148. View

17.

Yung M, Gould J, Upton G . Nasal polyposis in children with cystic fibrosis: a long-term follow-up study. Ann Otol Rhinol Laryngol. 2002; 111(12 Pt 1):1081-6. DOI: 10.1177/000348940211101204. View

18.

Daviskas E, Anderson S . Hyperosmolar agents and clearance of mucus in the diseased airway. J Aerosol Med. 2006; 19(1):100-9. DOI: 10.1089/jam.2006.19.100. View

19.

Southern K, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J . A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros. 2006; 6(1):57-65. DOI: 10.1016/j.jcf.2006.05.008. View

20.

Wood D, Smyth A . Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev. 2006; (1):CD004197. DOI: 10.1002/14651858.CD004197.pub2. View